4S eTrans SME is a complete freight forwarding system designed to automate, streamline and support multi-modal international freight forwarding operations.
Four Soft announced that it has signed a contract with Hamacher Logistik BV, Netherlands to implement its freight forwarding application 4S eTrans SME. Hamacher offers high quality, cost effective logistics solutions for exporters and importers globally.
Chris Veenstra, director – business development, Hamacher, said, “It was imperative for us to invest in a good IT application to automate our freight forwarding operations. We chose Four Soft for its state of the art technology and superior functionality of its application. It is a direct fit to our requirements.”
Willem van Anrooij, director, Four Soft said, “We are proud to be associated with a prestigious company like Hamacher Logistik BV.”
4S eTrans SME is a complete freight forwarding system designed to automate, streamline and support multi-modal international freight forwarding operations. It provides the logistics industry with a flexible and comprehensive software solution to manage business efficiently, increase productivity and improve the overall service to their customers.
In the early afternoon, Four Soft was trading at around Rs9.50 per share on the Bombay Stock Exchange, 4.74% up from the previous close.
Ranbaxy’s distribution network caters to 44 of the 54 countries in the African continent.
Ranbaxy Laboratories announced the opening of its new manufacturing facility at Casablanca, Morocco paving the way for a direct business presence in North Africa. With the successful audit of the facility by the Moroccan health authorities, Ranbaxy is now authorised to commence manufacturing at its Casablanca facility and gain access to a USD 1 billion pharmaceutical market in Morocco.
Commenting on the inauguration of the facility, Mahendra Bharadwaj, head Africa, Ranbaxy, said “Ranbaxy has a significant presence in Africa with its own ground operations in key markets. This reinforces our commitment to the people of Morocco and the African continent.”
The company now has three manufacturing facilities in Africa – the other two being located in Nigeria and South Africa. Its distribution network caters to 44 of the 54 countries in the continent.
In the early afternoon, Ranbaxy Laboratories was trading at around Rs418 per share on the Bombay Stock Exchange, 0.36% up from the previous close.
JSW Steel is planning to set up an electrical steel manufacturing facility of 0.6 MTPA capacity at its integrated steel works in Vijayanagar.
JSW Steel is now foraying into the manufacture of electrical steel. The company is planning to set up an electrical steel manufacturing facility of 0.6 MTPA capacity at its integrated steel works at Vijayanagar. Initially, this facility shall produce 0.4-0.5 MTPA of cold rolled non-grain oriented grade electrical steel. Implemented in a phased manner, JSW envisages becoming the largest electrical steel producer in the country.
JSW and JFE signed a strategic collaboration agreement in the year 2010. The collaboration is now being extended to electrical steel. JSW aspires to fully equip in order to adhere to the stringent quality standards required in electrical steel with the support of JFE.
The present demand of electrical steel is about 0.5 MTPA and it is expected to double by the year 2016-17. The demand is expected to grow at a CAGR of 15%. JSW expects to cater to the growth by scaling its manufacturing facilities.
In the early afternoon, JSW Steel was trading at around Rs755.35 per share on the Bombay Stock Exchange, 1.06% up from the previous close.